Rifampin Heteroresistance in Mycobacterium tuberculosis Cultures as Detected by Phenotypic and Genotypic Drug Susceptibility Test Methods
Author(s) -
Dorte Bek Folkvardsen,
Vibeke Østergaard Thomsen,
Leen Rigouts,
Erik Michael Rasmussen,
Didi Bang,
Gertjan Bernaerts,
Jim Werngren,
Juan Carlos Toro,
Sven Hoffner,
Doris Hillemann,
Erik Svensson
Publication year - 2013
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.01602-13
Subject(s) - mycobacterium tuberculosis , tuberculosis , microbiology and biotechnology , drug resistance , genotype , biology , rifampicin , antibiotics , virology , bacteria , medicine , genetics , gene , pathology
Tuberculosis patients may harbor both drug-susceptible and -resistant bacteria, i.e., heteroresistance. We used mixtures of rifampin-resistant and -susceptibleMycobacterium tuberculosis strains to simulate heteroresistance in patient samples. Molecular tests can be used for earlier discovery of multidrug resistance (MDR), but the sensitivity to detect heteroresistance is unknown. Conventional phenotypic drug susceptibility testing was the most sensitive, whereas two line probe assays and sequencing were unable to detect the clinically important 1% resistant bacteria.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom